These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9283205)

  • 1. [An investigation of drug abuse and the utility of toxicology screening for use in emergency centers].
    Inuzuka S; Hayashida M; Nihira M
    Nihon Ika Daigaku Zasshi; 1997 Aug; 64(4):344-52. PubMed ID: 9283205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
    Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
    J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
    Krasowski MD; Pizon AF; Siam MG; Giannoutsos S; Iyer M; Ekins S
    BMC Emerg Med; 2009 Apr; 9():5. PubMed ID: 19400959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y; Ojanperä I; Rasanen I; Vuori E
    Forensic Sci Int; 2003 Jan; 131(2-3):148-55. PubMed ID: 12590054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.
    Tomaszewski C; Runge J; Gibbs M; Colucciello S; Price M
    J Emerg Med; 2005 May; 28(4):389-94. PubMed ID: 15837018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimation of substance abuse in psychiatric patients by conventional hospital screening.
    Reidy LJ; Junquera P; Van Dijck K; Steele BW; Nemeroff CB
    J Psychiatr Res; 2014 Dec; 59():206-12. PubMed ID: 25262418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of MDMA and PCP by GC-MS from patients admitted to the critical care medical center].
    Nihira M; Hayakawa H; Yamada T; Hayashida M; Ohno Y; Miyauchi M; Yamamoto Y
    Chudoku Kenkyu; 2002 Jan; 15(1):47-52. PubMed ID: 11977736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica (Ephedraceae))].
    Nishiguchi M; Kinoshita H; Higasa K; Taniguchi T; Ouchi H; Minami T; Marukawa S; Yoshinaga K; Yamauchi J; Aoki S; Hishida S
    Nihon Hoigaku Zasshi; 2001 Nov; 55(3):331-8. PubMed ID: 11905042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug of abuse screening in urine in emergency situations; useful or not?].
    De Wit LE; Dekker D
    Ned Tijdschr Geneeskd; 2021 Feb; 164():. PubMed ID: 33651500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments.
    Peace MR; Poklis JL; Tarnai LD; Poklis A
    J Anal Toxicol; 2002 Oct; 26(7):500-3. PubMed ID: 12423007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast screening tests for the simultaneous detection of 11 drugs of abuse in urine specimens. A forensic epidemiology study of 28,298 cases in Tunisia.
    Moslah B; Araoud M; Nouioui MA; Najjar S; Amira D; Ben Salah N; Hedhili A
    Forensic Sci Int; 2018 Feb; 283():35-40. PubMed ID: 29248810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
    J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.